Unicycive Therapeutics (UNCY) Prepaid Assets (2020 - 2026)
Unicycive Therapeutics (UNCY) reported Prepaid Assets of $181000.0 for Q1 2026, down 86.77% on a YoY basis from $1.4 million in Q1 2025, and down 45.48% quarter-over-quarter from $332000.0 in Q4 2025.
Unicycive Therapeutics (UNCY) Prepaid Assets (2020 - 2026) Analysis & Trends
Unicycive Therapeutics has reported Prepaid Assets for 7 years, with the latest figure at $181000.0 in Q1 2026.
- For the quarter ending Q1 2026, Prepaid Assets fell 86.77% year-over-year to $181000.0; the trailing twelve-month figure through Mar 2026 stood at $181000.0 (down 86.77% YoY), and the FY2025 full-year result was $332000.0, down 93.09% from the prior year.
- Prepaid Assets for Q1 2026 stood at $181000.0, down from $332000.0 in the prior quarter.
- The five-year high for Prepaid Assets was $7.2 million in Q2 2025, with the low at $15000.0 in Q2 2024.
- Historically, Prepaid Assets has averaged $2.0 million across 5 years, with a median of $1.8 million in 2022.
- Annual changes were most pronounced in 2024 — Prepaid Assets tumbled 99.52% — and 2025, when it soared 47893.33%.
- Unicycive Therapeutics' Prepaid Assets stood at $2.2 million in 2022, then plunged by 87.67% to $270000.0 in 2023, then surged by 1680.0% to $4.8 million in 2024, then tumbled by 93.09% to $332000.0 in 2025, then plunged by 45.48% to $181000.0 in 2026.
- The last three Prepaid Assets figures came in at $181000.0 (Q1 2026), $332000.0 (Q4 2025), and $489000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - |
| 10 | Unicycive Therapeutics | 174.05 Mn | 119.47 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 181,000.00 |
| Dec 31, 2025 | 332,000.00 |
| Sep 30, 2025 | 489,000.00 |
| Jun 30, 2025 | 7.20 Mn |
| Mar 31, 2025 | 1.37 Mn |
| Dec 31, 2024 | 4.81 Mn |
| Sep 30, 2024 | 397,000.00 |
| Jun 30, 2024 | 15,000.00 |
| Mar 31, 2024 | 146,000.00 |
| Dec 31, 2023 | 270,000.00 |
| Sep 30, 2023 | 4.22 Mn |
| Jun 30, 2023 | 3.11 Mn |
| Mar 31, 2023 | 1.85 Mn |
| Dec 31, 2022 | 2.19 Mn |
| Sep 30, 2022 | 2.95 Mn |
| Jun 30, 2022 | 1.99 Mn |
| Mar 31, 2022 | 1.84 Mn |
| Dec 31, 2021 | 1.83 Mn |
| Sep 30, 2021 | 58,000.00 |
| Jun 30, 2021 | 10,000.00 |